These findings may say a lot more about a patient's long-term health than clinicians realized. 

Marielle Scherrer-Crosbie, MD, explains what is needed to create a cardio-oncology program, and the role played by cardiac imagers.

Juan Carlos Plana Gomez, MD, discussed how cardiology and oncology programs can work together to provide high-quality patient care.

The STOP-CA trial showed that statins can help chemotherapy patients avoid potential side effects related to anthracycline agents. Co-principal investigators Marielle Scherrer-Crosbie, MD, and Tomas Neilan, MD, discussed the details of that trial at ACC.23. 

Pediatric cardiologist Takeshi Tsuda, MD, discussed the evaluation of cardiotoxicity in young cancer patients at the American Heart Association (AHA) 2022 meeting.

The statement was written to fill gaps in recommendations from prior consensus statements and guidelines in regards to the use of CCT in cardio-oncology, including use of calcium scoring and ruling out coronary disease when cardiac function is impaired.

Overall, PCI patients appear to face a higher risk of in-hospital mortality, 30-day mortality and in-hospital cardiovascular mortality if they present with an active or historical cancer diagnosis. The group's analysis included data from nearly 6.6 million patients.

Specifically, doctors should consider adding routine global longitudinal strain to their surveillance of patients undergoing chemotherapy, experts argued recently.